Meningitis booster shot study for children aged 7-9
Part of Brain & nervous system, Infections clinical trials.
This trial tests a booster dose of a vaccine that protects against four types of meningococcal bacteria, which can cause meningitis (a serious infection of the lining around the brain). It is for children who already received this vaccine in a previous study and are now older.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have participated in an earlier study of this same vaccine (protocol CTP-MCVF-002).
- Your child must be included in both the IPS1 and IPS2 analysis sets of that previous study.
- It has been at least 3 years since your child finished their vaccine series in the earlier study.
- Your child has not received another meningococcal vaccine since then.
- Your child does not have a bleeding disorder, low platelets, or take blood-thinning medicine.
- Your child has not had meningitis since the end of the earlier study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new vaccine safely protects infants aged 6 to 11 months against four types of meningococcal bacteria that can cause serious infections like meningitis and blood infections. It is designed for healthy babies who have not yet received any meningococcal vaccine.
This study tests a vaccine that protects against four common types of meningitis (groups A, C, Y, and W135) in toddlers aged 12–23 months. It helps researchers see if the vaccine is safe and works well for young children.
This trial tests a vaccine that protects against four types of meningococcal bacteria (groups A, C, W, and Y) in healthy babies aged 3 to 5 months. The vaccine is given to help prevent meningitis and other serious infections.
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
This trial tests a new vaccine that helps protect against 6 types of meningococcal bacteria, which can cause serious infections like meningitis. It is for healthy people aged 2 to 59 years.
This study tests an experimental meningitis vaccine in healthy babies and toddlers to see how well it works and if it's safe. If your child is between 2 and 23 months old and in good health, they might be able to join.
Hear when a new Epidemic Meningitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.